Fundz

Anavo Therapeutics Appoints Edward Holson as Chief Scientific Officer and President of Anavo US

PRIVATEOct 09, 2024

Position

Chief Scientific Officer

Company

Anavo Therapeutics

Edward Holson
eholson@anavotx.com
BiotechnologyHealth CareTherapeutics

Description

Anavo Therapeutics has appointed Dr. Edward Holson, Ph.D., as the Chief Scientific Officer (CSO) and President of Anavo US

Quick answer

Anavo Therapeutics Appoints Edward Holson as Chief Scientific Officer and President of Anavo US (October 9, 2024).

Who is the new Chief Scientific Officer at Anavo Therapeutics?
Anavo Therapeutics named Edward Holson Chief Scientific Officer, announced October 9, 2024.
What did Anavo Therapeutics announce on October 9, 2024?
Anavo Therapeutics has appointed Dr. Edward Holson, Ph.D., as the Chief Scientific Officer (CSO) and President of Anavo US
What does Anavo Therapeutics do?
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
Which similar companies made leadership changes around the same time?
Immunome Inc. (October 8, 2024), bioAffinity Technologies (October 10, 2024), Nuvation Bio (October 7, 2024) and Anixa Biosciences (October 7, 2024) also announced leadership changes within 45 days of Anavo Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Anavo Therapeutics, and when

A new leader at Anavo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Anavo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Anavo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Anavo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Anavo Therapeutics

About

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Anavo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Edward
Likely contact at this company
••••••••@••••••••

See Edward's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Anavo Therapeutics's next move

Learn about Strategic plan

Anavo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.